000 | 01784 a2200505 4500 | ||
---|---|---|---|
005 | 20250517070821.0 | ||
264 | 0 | _c20160920 | |
008 | 201609s 0 0 eng d | ||
022 | _a1177-8881 | ||
024 | 7 |
_a10.2147/DDDT.S94207 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKoh-Stenta, Xiaoying | |
245 | 0 | 0 |
_aIdentification of covalent active site inhibitors of dengue virus protease. _h[electronic resource] |
260 |
_bDrug design, development and therapy _c2015 |
||
300 |
_a6389-99 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntiviral Agents _xchemistry |
650 | 0 | 4 |
_aCatalytic Domain _xdrug effects |
650 | 0 | 4 |
_aDengue Virus _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 |
_aProtease Inhibitors _xchemistry |
650 | 0 | 4 |
_aSerine Endopeptidases _xmetabolism |
650 | 0 | 4 |
_aSmall Molecule Libraries _xchemistry |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aViral Nonstructural Proteins _xantagonists & inhibitors |
700 | 1 | _aJoy, Joma | |
700 | 1 | _aWang, Si Fang | |
700 | 1 | _aKwek, Perlyn Zekui | |
700 | 1 | _aWee, John Liang Kuan | |
700 | 1 | _aWan, Kah Fei | |
700 | 1 | _aGayen, Shovanlal | |
700 | 1 | _aChen, Angela Shuyi | |
700 | 1 | _aKang, CongBao | |
700 | 1 | _aLee, May Ann | |
700 | 1 | _aPoulsen, Anders | |
700 | 1 | _aVasudevan, Subhash G | |
700 | 1 | _aHill, Jeffrey | |
700 | 1 | _aNacro, Kassoum | |
773 | 0 |
_tDrug design, development and therapy _gvol. 9 _gp. 6389-99 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2147/DDDT.S94207 _zAvailable from publisher's website |
999 |
_c25550831 _d25550831 |